All In Biotech

Investigational drug · Phase 2

TL-895

Not approved by FDA. In 1 industry-sponsored Phase 2 or 3 trial that is active or finished in the last two years, most often for Myelofibrosis, Primary Myelofibrosis, Post-PV MF.

Phase 2

Last checked: Nov 19, 2026Latest source record: Feb 21, 2023 (newest trial update)Source: ClinicalTrials.govMethods & limitations

Highest phase

Phase 2

Industry-sponsored trials

Phase 2 and 3 trials

1

1 still active

All registered trials

7

Any phase or sponsor naming "TL-895"

First trial start

2022

Jun 9, 2022

Sponsors

Lead sponsors of its Phase 2 and 3 trials.

All registered trials by phase

Every ClinicalTrials.gov drug study naming "TL-895", any sponsor or status.

Conditions studied

As listed on its trial records.

  • Myelofibrosis
  • Primary Myelofibrosis
  • Post-PV MF
  • Post-ET Myelofibrosis

Approved drugs for the same conditions: Myelofibrosis · Hematology and blood cancers

Largest trials

Live from ClinicalTrials.gov: studies naming "TL-895" as an intervention, largest first.

All trials

Newest research

PubMed records naming it or its code names, newest first.

All 3 on PubMed

Also in development for Myelofibrosis

  • ElriterceptTAK-226, KER-050Phase 36 trials

    Takeda · Myelodysplastic Syndromes, Myelofibrosis, Anemia

  • BomedemstatMK-3543, IMG-7289Phase 35 trials

    Merck & Co. · Polycythemia Vera, Essential Thrombocythemia, Thrombocythemia, Essential

  • RovadicitinibTQ05105Phase 35 trials

    Chia Tai Tianqing Pharmaceutical Group Co., Ltd. · Chronic Graft Versus Host Disease, Myelofibrosis, Graft-versus-host Disease

  • KRT-232NavtemadlinPhase 34 trials

    Kartos Therapeutics, Inc. · Diffuse Large B Cell Lymphoma, Chronic Lymphocytic Leukemia, Non Hodgkin Lymphoma

  • PelabresibDAK539, CPI-0610Phase 34 trials

    Novartis · Myelofibrosis, Primary Myelofibrosis, Primary Myelofibrosis (PMF)

  • BMS-986158Phase 22 trials

    Bristol Myers Squibb · Myelofibrosis, Multiple Myeloma

  • DISC-0974Phase 22 trials

    Disc Medicine, Inc · Anemia, Inflammatory Bowel Disease (IBD), Inflammatory Bowel Disease (IBD); Anemia

  • amsulostatPXS-5505Phase 21 trial

    Syntara · Myelofibrosis, Primary Myelofibrosis (PMF), Post- Essential Thrombocythemia Myelofibrosis

Names are merged from how sponsors list this drug on ClinicalTrials.gov, so an alias can occasionally belong to a related compound. Development status changes faster than registry records do.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.